ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1120

Analysis of SLE Plasmablasts By High Throughput Pairing of the Immunoglobulin Heavy and Light Chain (VH-VL)

Deepak Tomar1, Christopher Tipton1 and Ignacio Sanz2, 1Medicine/Rheumatology, Emory University School of Medicine, Atlanta, GA, 2Rheumatology, Emory University School of Medicine, Atlanta, GA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: B cells, monoclonal antibodies and technology, Plasmablasts, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In-depth analysis of the molecular and antigenic properties of antibody secreting cells (ASC) is critical for our understanding of autoimmune diseases.  This goal however has been hampered by technological barriers imposed by low-throughput technologies to interrogate the ASC at the single cell level.  We describe here the incorporation of a high throughput methodology for linking the B cell receptor’s heavy and light chain variable region (VH and VL) for analyzing the plasmablast B cell population from a SLE patient. Conventional techniques for sequencing of genomic DNA or cDNA from single cells are limited by low efficiency and low cell throughput (<200–500 cells), whereas >2 x 106B cells per experiment can be analyzed by this single-cell, emulsion-based technology for sequencing antibody VH-VL repertoires.   

Methods: We use a flow focusing apparatus to encapsulate the single B cells in to the emulsion droplets containing the lysis buffer and oligo dT magnetic beads for capturing the mRNA, followed by an emulsion RT-PCR for generating the VH and VL linked products for next generation sequencing. Approximately 50,000 plasmablasts (CD19+IgD-CD27highCD38highCD138neg) from a SLE patient were flow sorted and VH and VL transcript were linked using emulsion RT-PCR.  IgH, IgL and linked transcripts were sequenced via Illumina MiSeq.

Results: 20,000 different sequences representing over 2,200 different clonotypes were identified, thereby demonstrating a very polyclonal PB repertoire during Lupus flares.  High concordance was shown with Illumina miseq data obtained from bulk PB obtained from a separate aliquot of the same blood draw.  Both experiments also demonstrated the presence of substantial clonal expansions of the SLE-associated VH4-34 clones.     

Conclusion: We have incorporated a high-throughput methodology of linking immunoglubulin heavy and light chain variable region (VH-VL) transcripts prior to amplification and repertoire analysis via NGS. The ability of this approach to combine deep sequencing with single cell antibody generation should greatly enhance our understanding of the antigenic triggers involved in the pathogenesis of SLE and other autoimmune diseases.


Disclosure: D. Tomar, None; C. Tipton, None; I. Sanz, None.

To cite this abstract in AMA style:

Tomar D, Tipton C, Sanz I. Analysis of SLE Plasmablasts By High Throughput Pairing of the Immunoglobulin Heavy and Light Chain (VH-VL) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/analysis-of-sle-plasmablasts-by-high-throughput-pairing-of-the-immunoglobulin-heavy-and-light-chain-vh-vl/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-sle-plasmablasts-by-high-throughput-pairing-of-the-immunoglobulin-heavy-and-light-chain-vh-vl/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology